Novo Holdings Set to Exit Convatec Stake With 7.8% Offering
Novo Holdings A/S, a vehicle for the Novo Nordisk Foundation, is set to exit its remaining position in medical technology firm Convatec Group Plc with a 7.8% stake sale.
By Pablo Mayo Cerqueiro · Bloomberg Markets
Novo Holdings A/S, a vehicle for the Novo Nordisk Foundation, is set to exit its remaining position in medical technology firm Convatec Group Plc with a 7.8% stake sale.